These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37267953)

  • 1. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer.
    Haston S; Gonzalez-Gualda E; Morsli S; Ge J; Reen V; Calderwood A; Moutsopoulos I; Panousopoulos L; Deletic P; Carreno G; Guiho R; Manshaei S; Gonzalez-Meljem JM; Lim HY; Simpson DJ; Birch J; Pallikonda HA; Chandra T; Macias D; Doherty GJ; Rassl DM; Rintoul RC; Signore M; Mohorianu I; Akbar AN; Gil J; Muñoz-Espín D; Martinez-Barbera JP
    Cancer Cell; 2023 Jul; 41(7):1242-1260.e6. PubMed ID: 37267953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent Macrophages Promote KRAS-Driven Lung Tumorigenesis.
    Cancer Discov; 2023 Aug; 13(8):1758. PubMed ID: 37326376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescent alveolar macrophages promote early-stage lung tumorigenesis.
    Prieto LI; Sturmlechner I; Graves SI; Zhang C; Goplen NP; Yi ES; Sun J; Li H; Baker DJ
    Cancer Cell; 2023 Jul; 41(7):1261-1275.e6. PubMed ID: 37267954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.
    Baek KH; Bhang D; Zaslavsky A; Wang LC; Vachani A; Kim CF; Albelda SM; Evan GI; Ryeom S
    J Clin Invest; 2013 Oct; 123(10):4375-89. PubMed ID: 24018559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis.
    Tran PT; Shroff EH; Burns TF; Thiyagarajan S; Das ST; Zabuawala T; Chen J; Cho YJ; Luong R; Tamayo P; Salih T; Aziz K; Adam SJ; Vicent S; Nielsen CH; Withofs N; Sweet-Cordero A; Gambhir SS; Rudin CM; Felsher DW
    PLoS Genet; 2012; 8(5):e1002650. PubMed ID: 22654667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10.
    Yang J; Hou C; Wang H; Perez EA; Do-Umehara HC; Dong H; Arunagiri V; Tong F; Van Scoyk M; Cho M; Liu X; Ge X; Winn RA; Ridge KM; Wang X; Chandel NS; Liu J
    Cancer Lett; 2023 Feb; 555():216025. PubMed ID: 36538983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.
    Hill KS; Erdogan E; Khoor A; Walsh MP; Leitges M; Murray NR; Fields AP
    Oncogene; 2014 Apr; 33(16):2134-44. PubMed ID: 23604119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.
    Vicent S; Chen R; Sayles LC; Lin C; Walker RG; Gillespie AK; Subramanian A; Hinkle G; Yang X; Saif S; Root DE; Huff V; Hahn WC; Sweet-Cordero EA
    J Clin Invest; 2010 Nov; 120(11):3940-52. PubMed ID: 20972333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
    Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
    PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity.
    Li J; Wang Y; Luo Y; Liu Y; Yi Y; Li J; Pan Y; Li W; You W; Hu Q; Zhao Z; Zhang Y; Cao Y; Zhang L; Yuan J; Xiao ZJ
    Nat Commun; 2022 Dec; 13(1):7799. PubMed ID: 36528652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
    Valencia K; Erice O; Kostyrko K; Hausmann S; Guruceaga E; Tathireddy A; Flores NM; Sayles LC; Lee AG; Fragoso R; Sun TQ; Vallejo A; Roman M; Entrialgo-Cadierno R; Migueliz I; Razquin N; Fortes P; Lecanda F; Lu J; Ponz-Sarvise M; Chen CZ; Mazur PK; Sweet-Cordero EA; Vicent S
    J Clin Invest; 2020 Apr; 130(4):1879-1895. PubMed ID: 31874105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
    Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
    Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
    Green S; Trejo CL; McMahon M
    Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease.
    Yamada Z; Nishio J; Motomura K; Mizutani S; Yamada S; Mikami T; Nanki T
    Front Immunol; 2022; 13():935114. PubMed ID: 36059455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.
    Xiong J; Dong L; Lv Q; Yin Y; Zhao J; Ke Y; Wang S; Zhang W; Wu M
    Clin Transl Med; 2024 Sep; 14(9):e1772. PubMed ID: 39270064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of dystrophin expression in skeletal muscle is associated with senescence of macrophages and endothelial cells.
    Young LV; Morrison W; Campbell C; Moore EC; Arsenault MG; Dial AG; Ng S; Bellissimo CA; Perry CGR; Ljubicic V; Johnston AP
    Am J Physiol Cell Physiol; 2021 Jul; 321(1):C94-C103. PubMed ID: 33979211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
    Lau L; David G
    Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
    [No Abstract]   [Full Text] [Related]  

  • 20. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.